Abstract
Infections by hepatitis B or hepatitis C virus are still common among patients on maintenance dialysis in Western countries. The natural history of HBV and HCV in the dialysis population remains unclear; however, there is good evidence showing an adverse impact of an anti-HCV seropositive status on survival in dialysis patients. A recent meta-analysis of observational studies (n=7, 11,589 unique patients) reported that anti-HCV-positive patients on dialysis had a higher mortality rate than those who were anti-HCV negative (adjusted hazard ratio=1.35, 95% confidence interval, 1.13; 1.59, p
| Translated title of the contribution | The management of dialysis patients seropositive for HBsAg, anti-HCV, or anti-HIV antibodies |
|---|---|
| Original language | Italian |
| Pages (from-to) | S78-S84 |
| Journal | Giornale italiano di nefrologia : organo ufficiale della Società italiana di nefrologia |
| Volume | 29 |
| Publication status | Published - Sep 1 2012 |
ASJC Scopus subject areas
- Medicine(all)